These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33192856)

  • 1. Factorial Structure of the Serbian Version of the Clinical Assessment Interview for Negative Symptoms - Evidence for Three Factors of Negative Symptoms.
    Ristić I; Jerotić S; Zebić M; Savić B; Vuković V; Russo M; Voskresenski T; Jovanović N; Marić NP
    Front Psychol; 2020; 11():570356. PubMed ID: 33192856
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychometric Characteristics of the Macedonian Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Blaževska Stoilkovska B; Bajraktarov S; Markovska Simoska S; Milutinović M; Novotni L; Arsova S; Novotni G; Čalovska Samardziska V; Delova S; Novotni A; Jovanović N
    Psychiatr Danub; 2021; 33(3):347-353. PubMed ID: 34795177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
    Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
    Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Bengtsson J; Bodén R; Neider D; Cernvall M
    Nord J Psychiatry; 2022 Jan; 76(1):44-51. PubMed ID: 34126848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS).
    Jung SI; Woo J; Kim YT; Kwak SG
    J Korean Med Sci; 2016 Jul; 31(7):1114-20. PubMed ID: 27366011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms.
    Jang SK; Park SC; Choi KH; Yi JS; Park JK; Lee JS; Lee SH
    Psychiatry Investig; 2017 Jul; 14(4):413-419. PubMed ID: 28845167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Clinical Assessment Interview for Negative Symptoms (CAINS) in patients with depression and its relationship to affective symptoms.
    Bengtsson J; Rad P; Cernvall M; Bodén R
    Ann Gen Psychiatry; 2023 Oct; 22(1):42. PubMed ID: 37885022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia.
    Laraki Y; Lebrun C; Merenciano M; Eisenblaetter M; Attal J; Macgregor A; Decombe A; Capdevielle D; Raffard S
    Front Psychiatry; 2022; 13():836600. PubMed ID: 35432043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor structure and internal consistency of the Clinical Assessment Interview for Negative Symptoms (CAINS) on a sample of persons with psychotic disorders in Bosnia and Herzegovina.
    Kulenović AD; Mešević ES; Ribić E; Repišti S; Radojičić T; Jovanović N
    J Neural Transm (Vienna); 2022 Jul; 129(7):905-911. PubMed ID: 34878600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report.
    Kim JS; Jang SK; Park SC; Yi JS; Park JK; Lee JS; Choi KH; Lee SH
    Neuropsychiatr Dis Treat; 2016; 12():1167-72. PubMed ID: 27274251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
    Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
    Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
    Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.